Hepatic Metastases Terminated Phase 0 Trials for Cetuximab (DB00002)

Also known as: Metastases to liver / Liver Metastases / Metastatic neoplasm of liver / Cancer of liver, secondary / Metastasis to liver / Malignant neoplasm of liver, specified as secondary

IndicationStatusPhase
DBCOND0032606 (Hepatic Metastases)Terminated0
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00835679Cetuximab and/or Dasatinib in Patients With Colorectal Cancer and Liver Metastases That Can Be Removed by SurgeryBasic Science